61
Views
4
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Key Paper Evaluation

Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?

&
Pages 1243-1246 | Published online: 09 Jan 2014

References

  • Compston A, Coles A. Multiple sclerosis. Lancet372(9648), 1502–1517 (2008).
  • Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Rev. Neurother.8(10), 1585–1596 (2008).
  • Zipoli V, Goretti B, Hakiki B et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult. Scler.16(1), 62–67 (2010).
  • Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology70(20), 1891–1897 (2008).
  • Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology75(13), 1134–1140 (2010).
  • Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch. Neurol.58(10), 1602–1606 (2001).
  • Amato MP, Portaccio E, Stromillo ML et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology71(9), 632–638 (2008).
  • Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology63(9), 1579–1585 (2004).
  • Krupp LB, Christodoulou C, Melville P et al. Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology76(17), 1500–1507 (2011).
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology33(11), 1444–1452 (2983).
  • Rao S. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Medical College of Wisconsin, WI, USA (1990).
  • Benedict RH, Fischer JS, Archibald CJ et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin. Neuropsychol.16(3), 381–397 (2002).
  • Amato MP. Donepezil for memory impairment in multiple sclerosis. Lancet Neurol.4(2), 72–73 (2005).
  • Sicotte NL, Kern KC, Giesser BS et al. Regional hippocampal atrophy in multiple sclerosis. Brain131(Pt 4), 1134–1141 (2008).
  • Filippi M, Rocca MA, Benedict RH et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology75(23), 2121–2128 (2010).
  • Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol.7(12), 1139–1151 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.